Table 1.
Methylation Levels of Patients With GOM at IC1 and LOM at IC2
Patient No. | IC1 Methylation | Normal Range | IC2 Methylation | Normal Range | |
---|---|---|---|---|---|
Patients with Wilms tumor | 1 | 53.81% ± 0.80% | 50.00% ± 1.12% | Normal | |
2 | 55.11% ± 2.00% | 50.00% ± 0.98% | Normal | ||
3 | 56.28% ± 1.58% | 50.00% ± 1.54% | Normal | ||
4 | 54.10% ± 0.88% | 50.00% ±‐ 0.97% | Normal | ||
5 | 54.48% ± 0.96% | 50.00% ±‐ 1.08% | Normal | ||
6 | 55.24% ± 0.95% | 50.00% ± 1.51% | Normal | ||
7 | Normal | Normal | |||
8 | Normal | Normal | |||
9 | Normal | Normal | |||
10 | Normal | Normal | |||
11 | Normal | Normal | |||
12 | Normal | Normal | |||
13 | Normal | Normal | |||
14 | Normal | Normal | |||
15 | Normal | Normal | |||
16 | Normal | Normal | |||
17 | Normal | Normal | |||
18 | Normal | Normal | |||
19 | Normal | Normal | |||
20 | Normal | Normal | |||
21 | Normal | Normal | |||
Patients with hepatoblastoma | 22 | 56.23% ± 0.84% | 50.00% ± 1.61% | Normal | |
23 | Normal | 40.44% ± 1.68% | 49.99% ± 0.97% | ||
24 | Normal | Normal |
Abbreviations: GOM, gain of methylation; IC1, imprinting control 1; IC2, imprinting control 2; LOM, loss of methylation.